Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | BNTX | RVMD | ||
| Company | Biogen Inc | Biontech Se ADR | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 168.87 | 109.24 | 124.45 | ||
| High | 169.34 | 111.26 | 124.49 | ||
| Low | 163.74 | 107.91 | 119.61 | ||
| Latest | 164.42 | 109.00 | 120.28 | ||
| Change | -4.15 | +2.93 | -2.99 | ||
| % Change | -2.46% | +2.76% | -2.43% | ||
| Volume | 1,816,500 | 1,192,400 | 4,798,600 | ||
| 20-Day Average Volume | 2,221,330 | 1,167,725 | 4,826,395 | ||
| Previous Close | 168.57 | 106.07 | 123.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 176.93 | 98.47 | 94.26 | ||
| 20-Day Raw Stochastic | 2.59% | 88.78% | 91.63% | ||
| 20-Day Relative Strength | 41.19 | 65.64 | 82.81 | ||
| Weighted Alpha | +20.99 | +1.78 | +192.56 | ||
| Today's Opinion | 56% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 56% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.37% since 01/09/26 | +9.16% since 01/09/26 | +1.38% since 01/09/26 | ||
| Low | 163.74 on 01/16/26 | 99.13 on 01/12/26 | 113.33 on 01/12/26 | ||
| High | 188.00 on 01/12/26 | 111.26 on 01/16/26 | 124.49 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | -4.13% since 12/16/25 | +18.18% since 12/16/25 | +55.08% since 12/16/25 | ||
| Low | 163.74 on 01/16/26 | 91.11 on 12/18/25 | 74.20 on 12/18/25 | ||
| High | 190.20 on 01/09/26 | 111.26 on 01/16/26 | 124.49 on 01/16/26 | ||
| 3-Month | |||||
| %Chg | +15.58% since 10/16/25 | +3.73% since 10/16/25 | +142.11% since 10/16/25 | ||
| Low | 138.00 on 10/30/25 | 91.11 on 12/18/25 | 52.40 on 10/17/25 | ||
| High | 190.20 on 01/09/26 | 113.39 on 11/12/25 | 124.49 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | +27.99% since 07/16/25 | -3.10% since 07/16/25 | +213.23% since 07/16/25 | ||
| Low | 121.05 on 07/21/25 | 90.12 on 09/12/25 | 34.00 on 08/07/25 | ||
| High | 190.20 on 01/09/26 | 115.54 on 07/25/25 | 124.49 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,120,742 | 24,544,838 | 23,252,530 | ||
| Shares Outstanding, K | 146,702 | 225,182 | 193,320 | ||
| Annual Sales | 9,675,900,000 | 2,976,970,000 | 0 | ||
| Annual Net Income | 1,632,200,000 | -719,920,000 | -600,090,000 | ||
| Last Quarter Sales | 2,534,700,000 | 1,775,440,000 | 0 | ||
| Last Quarter Net Income | 466,500,000 | -33,550,000 | -305,210,000 | ||
| 60-Month Beta | 0.13 | 1.40 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.81 on 10/30/25 | -0.14 on 11/03/25 | -1.61 on 11/05/25 | ||
| Latest Earnings Date | 02/06/26 | 03/09/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | 3.084 on 06/02/22 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/02/22 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.07 | 0.00 | 0.00 | ||